- Report
- April 2021
- 47 Pages
Global
€21269EUR$22,000USD£18,269GBP
- Drug Pipelines
- June 2019
- 579 Pages
Global
€21269EUR$22,000USD£18,269GBP
- Report
- June 2019
- 18 Pages
Global
€9668EUR$10,000USD£8,304GBP
- Report
- February 2021
- 254 Pages
Global
From €10630EUR$10,995USD£9,130GBP
- Report
- February 2021
- 58 Pages
Global
From €3862EUR$3,995USD£3,318GBP
- Report
- December 2019
- 63 Pages
Global
From €6763EUR$6,995USD£5,809GBP
- Report
- April 2021
- 64 Pages
Global
€21269EUR$22,000USD£18,269GBP
- Report
- January 2019
- 717 Pages
Global
From €21269EUR$22,000USD£18,269GBP
- Report
- June 2021
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- April 2019
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- June 2019
- 14 Pages
Global
€9668EUR$10,000USD£8,304GBP
- Report
- June 2019
- 26 Pages
Global
€9668EUR$10,000USD£8,304GBP
- Report
- January 2024
- 95 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- September 2022
- 89 Pages
Global
From €3384EUR$3,500USD£2,906GBP
- Report
- February 2024
- 182 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- February 2024
- 173 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- May 2023
- 160 Pages
Global
From €5800EUR$5,999USD£4,982GBP
The antiretroviral market is a subset of the HIV/AIDS drugs market, which is focused on the development and sale of drugs that can be used to treat HIV/AIDS. Antiretroviral drugs are used to reduce the amount of HIV in the body, and can be used to prevent the transmission of HIV from one person to another. These drugs are typically used in combination with other treatments, such as counseling and lifestyle changes, to help people living with HIV/AIDS manage their condition.
The antiretroviral market is highly competitive, with many companies developing and selling drugs to treat HIV/AIDS. Some of the major players in the market include Gilead Sciences, Merck, Bristol-Myers Squibb, GlaxoSmithKline, and ViiV Healthcare. Other companies, such as AbbVie, Janssen, and Mylan, also have a presence in the market. Show Less Read more